| [1] |
Jemal A, Siegel R, Xu J, et al. Cancer statistics,2010 [J]. CA Cancer J Clin,2010,60(5):277-300.
|
| [2] |
La Vecchia C, Bosetti C, Lucchini F, et al. Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975[J]. Ann Oncol,2010,21(6):1323-1360.
|
| [3] |
Vincent-Salomon A,Thiery JP. Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development [J]. Breast Cancer Res,2003,5(2):101-106.
|
| [4] |
Aokage K,Ishii G,Ohtaki Y,et al. Dynamic molecular changes associated with epithelial-mesenchymal transition and subsequent mesenchymal-epithelial transition in the early phase of metastatic tumor formation[J]. Int J Cancer,2011,128(7):1585-1595.
|
| [5] |
Geiger TR, Peeper DS. Metastasis mechanisms [J]. Biochim Biophys Acta,2009,1796(2):293-308.
|
| [6] |
Weinberg RA. The Biology of Cancer [M]. New York:Garland Science, Taylor & Francis Group,2007:559.
|
| [7] |
Zheng G, Lyons JG, Tan TK, et al. Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelialmesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells [J]. Am J Pathol,2009,175(2):580-591.
|
| [8] |
Schmalhofer O,Brabletz S,Brabletz T. E-cadherin,beta-catenin, and ZEB1 in malignant progression of cancer [J]. Cancer Metastasis Rev,2009,28(1/2):151-166.
|
| [9] |
Ooshio T, Kobayashi R, Ikeda W, et al. Involvement of the interaction of afadin with ZO-1 in the formation of tight junctions in Madin-Darby canine kidney cells [J]. J Biol Chem,2010,285(7):5003-5012.
|
| [10] |
Ohtani S, Terashima M, Satoh J, et al. Expression of tight-junction-associated proteins in human gastric cancer:downregulation of claudin-4 correlates with tumor aggressiveness and survival [J]. Gastric Cancer,2009,12(1):43-51.
|
| [11] |
Jung H, Jun KH, Jung JH, et al. The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue [J]. J Surg Res,2011,167(2):185-191.
|
| [12] |
Szasz AM,Tokes AM,Micsinai M,et al. Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis [J]. Clin Exp Metastasis,2011,28(1):55-63.
|
| [13] |
Radisky ES,Radisky DC. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer [J]. J Mammary Gland Biol Neoplasia,2010,15(2):201-212.
|
| [14] |
Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment [J].Cell,2010,141(1):52-67.
|
| [15] |
Daniele A, Zito AF, Giannelli G, et al. Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer [J]. Anticancer Res,2010,30(9):3521-3527.
|
| [16] |
Chang HJ, Yang MJ, Yang YH, et al. MMP13 is potentially a new tumor marker for breast cancer diagnosis [J]. Oncol Rep,2009,22(5):1119-1127.
|
| [17] |
邓晓莉,李建一,张文海. MMP-2 和MMP-13 与乳腺癌腋窝淋巴结转移的相关性[J].中华内分泌外科杂志,2011,5(6):293-297.
|
| [18] |
Gos M, Miloszewska J, Przybyszewska M. Epithelial-mesenchymal transition in cancer progression [J]. Postepy Biochem,2009,55(2):121-128.
|
| [19] |
Moreno-Bueno G,Portillo F,Cano A. Transcriptional regulation of cell polarity in EMT and cancer [J]. Oncogene,2008,27(55):6958-6969.
|
| [20] |
Klinghoffer RA, Magnus J, Schelter J, et al. Reduced seed region-based off-target activity with lentivirus-mediated RNAi[J]. RNA,2010,16(5):879-884.
|
| [21] |
Scarola M, Schoeftner S, Schneider C, et al. miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response [J]. Cancer Res,2010,70(17):6925-6933.
|
| [22] |
Wang X, Ling C, Bai Y, et al. MicroRNA-206 is associated with invasion and metastasis of lung cancer [J]. Anat Rec(Hoboken),2011,294(1):88-92.
|
| [23] |
Bhaumik D, Scott GK, Schokrpur S, et al. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells [J]. Oncogene,2008,27(42):5643-5647.
|
| [24] |
Valastyan S,Chang A,Benaich N,et al. Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis[J]. Cancer Res,2010,70(12):5147-5154.
|
| [25] |
Ma L. Role of miR-10b in breast cancer metastasis [J]. Breast Cancer Res,2010,12(5):210.
|
| [26] |
Huang Q, Gumireddy K, Schrier M, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis [J]. Nat Cell Biol,2008,10(2):202-210.
|
| [27] |
Lou Y, Yang X, Wang F, et al. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein [J]. Int J Mol Med,2010,26(6):819-827.
|
| [28] |
Zhang X, Liu S, Hu T, et al. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression [J]. Hepatology,2009,50(2):490-499.
|
| [29] |
Segura MF, Hanniford D, Menendez S, et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor [J]. Proc Natl Acad Sci USA,2009,106(6):1814-1819.
|
| [30] |
Heimann R, Hellman S. Aging, progression, and phenotype in breast cancer [J]. J Clin Oncol,1998,16(8):2686-2692.
|
| [31] |
Han M, Wang Y, Liu M, et al. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells [J]. Cancer Sci,2012. doi: 10.1111/j.1349-7006.2012.02281.x.
|
| [32] |
Connolly EC, Van Doorslaer K, Rogler LE, et al. Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB [J]. Mol Cancer Res,2010,8(5):691-700.
|